Who are Diltiazem Injectable Product's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Olmesartan medoxomil ＋Azelnidipine, Amlodipine + Perindopril, nicardipine intravenous, Amlodipine plus Metformin, Amlodipine + Simvastatin, Calcium Channel Blockers.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/diltiazem-injectable-product.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-17 · How we verify

Diltiazem Injectable Product — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Diltiazem Injectable Product (Diltiazem Injectable Product) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Non-dihydropyridine calcium channel blocker. Area: Cardiovascular.

marketed Non-dihydropyridine calcium channel blocker L-type voltage-gated calcium channel Cardiovascular Small molecule Live · refreshed every 30 min

Target snapshot

Diltiazem Injectable Product (Diltiazem Injectable Product) — Virginia Commonwealth University. Diltiazem is a non-dihydropyridine calcium channel blocker that inhibits calcium influx into cardiac and vascular smooth muscle cells, reducing heart rate and blood pressure.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
Diltiazem Injectable Product TARGET	Diltiazem Injectable Product	Virginia Commonwealth University	marketed	Non-dihydropyridine calcium channel blocker	L-type voltage-gated calcium channel
Olmesartan medoxomil ＋Azelnidipine	Olmesartan medoxomil ＋Azelnidipine	Jichi Medical University	marketed	Antihypertensive combination (ARB + calcium channel blocker)	Angiotensin II type 1 receptor (AT1R) and L-type voltage-gated calcium channels
Amlodipine + Perindopril	Amlodipine + Perindopril	Centre for Chronic Disease Control, India	marketed	Calcium channel blocker + ACE inhibitor combination	L-type voltage-gated calcium channels; Angiotensin-converting enzyme (ACE)
nicardipine intravenous	nicardipine intravenous	Haseki Training and Research Hospital	marketed	Dihydropyridine calcium channel blocker	L-type voltage-gated calcium channel
Amlodipine plus Metformin	Amlodipine plus Metformin	Third Military Medical University	marketed	Combination therapy: calcium channel blocker + biguanide antidiabetic	L-type voltage-gated calcium channels (amlodipine); AMP-activated protein kinase and mitochondrial glycerophosphate dehydrogenase (metformin)
Amlodipine + Simvastatin	Amlodipine + Simvastatin	University of Pavia	marketed	Calcium channel blocker + HMG-CoA reductase inhibitor (statin)	L-type voltage-gated calcium channel; HMG-CoA reductase
Calcium Channel Blockers	Calcium Channel Blockers	Hospital de Clinicas de Porto Alegre	marketed	Calcium channel blocker	L-type voltage-gated calcium channel

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Non-dihydropyridine calcium channel blocker class)

Oman Medical Speciality Board · 1 drug in this class
Seoul National University Hospital · 1 drug in this class
Virginia Commonwealth University · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Diltiazem Injectable Product — Competitive Intelligence Brief. https://druglandscape.com/ci/diltiazem-injectable-product. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab